Long-term treatment with simvastatin leads to reduced migration capacity of prostate cancer cells

HIGHLIGHTS

• who: Mona Kafka and colleagues from the Department of Urology, Medical University Innsbruck, Anichstrau00dfe, Innsbruck, Austria have published the paper: Long-Term Treatment with Simvastatin Leads to Reduced Migration Capacity of Prostate Cancer Cells, in the Journal: Biomedicines 2023, 29 of 24/02/2021
• what: The authors investigated the short-term effects of three different statins (simvastatin atorvastatin and rosuvastatin) in various PCa cell lines mimicking androgen-sensitive and -insensitive PCa. As statins are a long-term and often even a life-long medication in patients with hypercholesterolemia or a cardiovascular risk profile, the authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.